Ariad Pharma Revenue, Profits - ARIA Annual Income Statement

Add to My Stocks
$23.99 $0 (0%) ARIA stock closing price Feb 16, 2017 (Closing)

Fundamental analysis of ARIA stock involves analyzing its financial statements, apart from checking the Ariad Pharma stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 105.41M to 118.8M and how operating and non operating activities have impacted the ARIA stock. One also needs to look at Ariad Pharma assets, operating expenses and Ariad Pharma free cash flow. The Ariad Pharma profit and loss statement shows revenue of $118.8M for 2015. Revenue has grown by 12.7% YOY for ARIA stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Ariad Pharma Revenues or Net Sales
118.8M105.41M45.56M-25.3M178.98M8.3M7.08M
Cost Of Goods Sold (COGS)2.11M5.22M9.61M-----
Ariad Pharma Gross Profit
116.69M100.18M35.94M-25.3M178.98M8.3M7.08M
Research & Development Expense171.21M120.59M162.9M144.7M77.74M57.98M63.44M50.84M
Selling General & Admin Expense162.75M139.79M146.61M60.9M24.38M16.09M16.88M28.09M
Income Before Depreciation Depletion Amortization-217.27M-160.19M-273.56M-205.06M-76.82M104.9M-72.03M-71.85M
Depreciation Depletion Amortization--------
Non Operating Income-6.29M--15.61M-46.54M-19.44M-7.68M1.34M
Interest Expense18.14M8.07M------
Ariad Pharma Pretax Income
-234.55M-161.97M-273.71M-220.87M-123.6M85.24M-80M-71.05M
Provision for Income Taxes-3.39M-------
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-231.15M-162.6M-274.15M-220.87M-123.6M85.24M-80M-71.05M
Extraordinary Items & Discontinued Operations--------
Ariad Pharma Profit/ Loss (Net Income)
-231.15M-162.6M-274.15M-220.87M-123.6M85.24M-80M-71.05M
Average Shares used to compute Diluted EPS188.67M186.84M183.58M164.96M132.38M114.73M93.33M69.79M
Average Shares used to compute Basic EPS188.67M186.84M183.58M164.96M132.38M113.02M93.33M69.79M
Income Before Nonrecurring Items-221.73M-162.6M-274.16M-220.87M-123.6M85.25M-80.01M-71.05M
Income from Nonrecurring Items-9.43M-------
Ariad Pharma Earnings Per Share Basic Net
-1.23-0.87-1.49-1.34-0.930.75-0.86-1.02
Ariad Pharma Earnings Per Share Diluted Net
-1.23-0.87-1.49-1.34-0.930.74-0.86-1.02
EPS Diluted Before Nonrecurring Items-1.18-0.87-1.49-1.34-0.930.74-0.86-1.02
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Ariad Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Ariad Pharma revenue chart, as is the case with Ariad Pharma indicates a growing business. One needs to compare the YoY topline or sales growth of ARIA stock with its peers like FGEN stock and NPSP stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. ARIA stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the ARIA income statement, one can check the Ariad Pharma historical stock prices to check how the price has moved with time.

Ariad Pharma Income Statement - Key Financial Ratios